Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 18/20 | 0.52 |
| ▸ | PDE4A | P27815 | 12/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 12/20 | 0.50 |
| ▸ | PDE4C | Q08493 | 12/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 12/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13849042 | 0.89 | CYP2C9 (0.50) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4039946 | 0.83 | CYP2C9 (0.74) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4031519 | 0.81 | PDE4A (0.58) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5256469 | 0.81 | CYP2C9 (0.77) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| Alcohol SCHEMBL4026942 | 0.80 | PDE4A (0.58) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4025781 | 0.75 | PDE4A (0.66) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5260429 | 0.74 | CYP2C9 (0.81) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8363168 | 0.73 | CYP2C9 (0.51) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4035923 | 0.72 | CYP2C9 (0.71) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5256640 | 0.72 | CYP2C9 (0.73) | CYP2C9PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1487797-B1 | HETERO-BRIDGE SUBSTITUTED 8-ARYLQUINOLINE PDE4 INHIBITORS | MERCK FROSST CANADA LTD (CA) | 2009-05-27 | — | — | EP | disclosed |